Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial

American Journal of Transplantation(2024)10.1016/j.ajt.2024.03.007Source: DataRank Database

Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial is a research paper published in American Journal of Transplantation (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.46)OA: bronzeTopics (58)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Bryna E. Burrell ORCID,Jonathan S. Bromberg ORCID,Choli Hartono ORCID,Dixon B. Kaufman ORCID,Andrew M. Possselt

Live enrichment

PubMed:38467375 OpenAlex:https://openalex.org/W4392655355

NIAID

Grant: UM1AI109565

National Institutes of Health

Grant: UM2AI117870

Immune Tolerance Network

FWCI

1.46

Citation Percentile

0.8%

Citation Trend

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.amjtransplant.org/article/S1600613524002028/pdf

publisherhttp://www.amjtransplant.org/article/S1600613524002028/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1600613524002028?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1600613524002028?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ajt.2024.03.007

Fields of Study

Renal Transplantation Outcomes and TreatmentsNeurological Complications and SyndromesCytomegalovirus and herpesvirus researchHumansKidney TransplantationAntilymphocyte SerumRituximabFemaleMaleLiving DonorsMiddle AgedProspective StudiesGraft RejectionAdultImmunosuppressive AgentsFollow-Up StudiesPilot ProjectsGraft SurvivalKidney Failure, ChronicPrognosisImmunosuppression TherapyKidney Function TestsTransplant Recipients

MeSH Terms

RituximabAdultAntilymphocyte SerumFemaleFollow-Up StudiesGraft RejectionGraft SurvivalHumansImmunosuppression TherapyImmunosuppressive AgentsKidney Failure, ChronicKidney Function TestsMaleMiddle AgedPilot ProjectsPrognosisProspective StudiesKidney TransplantationLiving DonorsTransplant Recipients

Keywords

MedicineImmunosuppressionRituximabRenal transplantClinical trialInternal medicineImmunologyGlobulinTransplantationAntibodyKidney transplantationT Cell DepletionOperational ToleranceB Cell DepletionAntithymocyte